You are here

Responses

Article menu
Download PDFPDF
Letter
Unexpected impact of COVID-19 lockdown on spinal mobility and health perception in spondyloarthritis
Compose a Response to This Article
Compose Response

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on: 20 April 2022
    Correspondence on “Unexpected impact of COVID-19 lockdown on spinal mobility and health perception in spondyloarthritis” by De Mits S, De Craemer A-S, Deroo L, et al.
    • Pauline BREVET, Rheumatologist Rouen University Hospital
    • Other Contributors:
      • Thierry LEQUERRE, Rheumatologist
      • Olivier VITTECOQ, Rheumatologist

    We read with great interest the article reported by De Mits and colleagues [1] suggesting that lockdown during the COVID-19 pandemic decreased chest expansion but did not have any impact on spinal mobility or disease activity in patients with spondyloarthritis (SpA).
    We conducted a similar study in France during the first lockdown (17th March-10th May 2020), which included all patients with SpA from our centre, who received bDMARDs administered intravenously in the immunotherapy unit of our outpatient clinic. In this unit, a standardized procedure is applied to collect clinical, biological and if necessary, imaging data at each clinical visit. During this period of lockdown, patients had at least one clinical examination. The Visual Analog Scale (VAS) values for pain, asthenia and activity, as well as the BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) and BASFI (Bath Ankylosing Spondylitis Functional Index) were collected and averaged from two clinical visits, one before (pre-lockdown) and one after (post-lockdown) and then compared with the data collected during lockdown. Fifty-nine patients ((mean ± SD) 52±12 years at the time of the study, 33 men, 26 women) were included during the study period. All patients had stable disease and none developed COVID-19 symptoms during this period. We also included a cohort of 50 patients (mean age of 62 years at the time of the study, 10 men, 40 women) with rheumatoid arthritis. The VAS values for pain, asthenia and...

    Show More
    Conflict of Interest:
    None declared.